FDA and CDC Warn About Flesh-Eating Diseases
US Government Agencies are concerned that certain types of diabetes drugs can cause Fournier's gangrene
Monday, February 18, 2019 - The Center for Disease Control (CDC) promotes acting fast in order to minimize the devastating effects of necrotizing fasciitis or skin-eating disease. Necrotizing fasciitis is a fast-spreading and potentially lethal disease. Treatment for the disease is limited to debridement, the removal of dead tissue, followed by full-spectrum antibiotics both intravenously and also packed into the open wound. Doctors usually cut away a fair amount of seemingly healthy tissue to ensure that they have removed all of the necrotic tissue, much like forest firefighters back burn to stop the spread of a fire. The CDC warns that necrotizing fasciitis patients experience fever, dizziness, and nausea after having surgery or suffering an injury.
Diabetic patients taking certain SLGT2 blocker medications called sodium-glucose cotransporter-2 (or SGLT2) inhibitors, such as the popular Invokana, have reported developing a certain substrain of necrotizing fasciitis called Fournier's gangrene. Fournier's gangrene usually occurs in males and destroys the tissue of the male genitalia in between the anus an scrotum. The FDA described the outbreak of Fournier's gangrene as a form of "necrotizing fasciitis of the perineum." In addition to the CDC warnings on necrotizing fasciitis, the US Food and Drug Administration (FDA) has expressed concern that an outbreak of Fournier's gangrene may have occurred. As recently as September of 2018, the FDA issued a warning entitled: "FDA warns about rare occurrences of a serious infection of the genital area with SGLT2 inhibitors for diabetes."
According to FDA podcast sources, "SGLT2 inhibitors are FDA-approved for use with diet and exercise to lower blood sugar in adults with type 2 diabetes. They lower blood sugar by causing the kidneys to remove sugar from the body through the urine. Medicines in the SGLT2 inhibitor class include canagliflozin, dapagliflozin, empagliflozin, and ertugliflozin." Fournier's gangrene is a bacterial infection that can enter the tissue that lies just below the skin and above the muscle, nerve, fat tissues and blood vessels of the perineum, is extremely rare and affects only about 1 in 50,000 males annually in the US, usually males 50-79, according to the FDA. 12 cases of Fournier's gangrene have been identified in which 7 were male. All developed the disease within 6 months of starting SGLT2 inhibitor drugs and required surgery including radical amputation of the male genitalia.
The FDA has issued a warning that the following diabetes drugs have been linked to Fournier's gangrene, a rare but often deadly genital flesh-eating disease. If you are taking any of the following diabetes medications, please consult your physician immediately. Canagliflozin (Invokana, Invokamet, Invokamet XR), Dapagliflozin (Farxiga, Xigduo XR, Qtern), Empagliflozin (Jardiance, Glyxambi, Synjardy, Synjardy XR), and Ertugliflozin (Steglatro, Segluromet, Steglujan). If you are taking any of the diabetes drugs listed above and experience redness, blisters, skin discoloration or skin ulcers, swelling, and pain in the affected area accompanied by a high fever, nausea, vomiting, and other flu-like symptoms, like fatigue and diarrhea, do not discontinue using the drug but see your physician immediately.
More Recent Diabetes Drug Infection Lawsuit News:
- Heart Disease Patients May Soon Be Prescribed Farxiga | 7/23/2020
- Diabetic Drug Farxiga Emerges As A Potential Cause of Fournier's Gangrene | 7/20/2020
- Diabetic Drug Companies Fail To Adequately Warn Patients of The Dangers of Developing Fournier's Gangrene | 7/15/2020
- A High Profile Fournier's Gangrene Victim May Serve To Increase Public Awareness | 6/25/2020
- The Flesh-Eating Disease Could Grow Exponentially in Summer of 2020 | 6/16/2020
- AstraZeneca Pharmaceutical Web Site Warns Patient About Possible Bacterial Infections | 6/5/2020
- New Fournier's Gangrene Victim Files Lawsuit Against AstraZeneca Pharmaceuticals LP | 6/3/2020
- Fornier's Gangrene is Easily Overlooked And Could be Called Complications From the Coronavirus | 5/26/2020
- Diabetic Nursing Home Patients May Be Dying From Fournier's Gangrene | 5/15/2020
- Diabetic Patients Taking SGLT2 Diabetic Drugs Could Be At Risk of Dying from COVID19 | 4/27/2020
- Fournier's Gangrene Looks Like Frostbite Except For Its Location | 4/21/2020
- Fournier's Gangrene More Likely Than Nursing Home Neglect In Patient's Death | 4/9/2020
- Nursing Homes Need To Pay Attention To Diabetic Patients Developing Fournier's Gangrene | 3/31/2020
- New Warning For SGLT2 Diabetes Drugs Include Fournier's Gangrene | 3/19/2020
- Popular Diabetic Drug Companies Are Warned To Alert Diabetic Patients of the Risks of Developing Fournier's Gangrene | 3/12/2020
- Patient's Fournier's Gangrene Can Be Mistaken For Ordinary Nursing Home Neglect | 3/5/2020
- Nursing Home Patients Taking Diabetic Medication Must Be Monitored For Fournier's Gangrene | 2/25/2020
- Simple Necrotizing Fasciitis Can Lead To Gruesome Fournier's Gangrene | 2/7/2020
- Fournier's Gangrene Can Cause Elephantitis of the Scrotum | 2/3/2020
- Diabetic Drugs Linked to Fournier's Gangrene May Treat Heart Conditions | 1/29/2020
- The Annals of Medicine Examines the Relationship Between Certain Diabetic Drugs and Fournier's Gangrene | 1/8/2020
- Diabetic Medications Can Cause Fournier's Gangrene And Other Health-Threatening Conditions | 12/31/2019
- Fournier's Gangrene Can Leave a Survivor Severely Depressed | 12/20/2019
- Woman's Cosmetic Surgery Leads to Flesh-Eating Disease of the Genitals | 12/16/2019
- Women Diagnosed With Orbital Necrotizing Fasciitis | 12/2/2019
- The Flesh-Eating Disease Has Made The News In 2019 | 11/22/2019
- Diabetic Drugs Can Weaken The Immune System Leading To Fournier's Gangrene | 11/11/2019
- SGLT-2 Drug Makers Are Being More Forthcoming About Links To Fournier's Gangrene | 10/31/2019
- Drug Marketers Are Finding Creative Applications For SGLT-2 Drugs Ignoring The Risk of Fournier's Gangrene | 10/24/2019
- Patient Contracts Flesh-Eating Disease While Giving Birth in a New York Hospital | 10/15/2019
- Weakened Immune Systems May Be The Cause of The Outbreak in Flesh-Eating Disease | 10/3/2019
- Fournier's Gangrene Stories Are One More Shocking Than Then The Last | 10/2/2019
- Sodium-Glucose Blocker Drugs and The Flesh-Eating Disease | 9/18/2019
- Diabetic Patients Are At Risk For Developing Fournier's Gangrene Mistaken as The Ordinary Flesh-Eating Disease | 9/2/2019
- SGLT2 Inhibitor Drugs Can Now Include Reducing Heart Disease on Their Labels In Europe | 8/29/2019
- Fournier's Gangrene Can Develop In Elderly Nursing Home Patients | 8/23/2019
- Elderly Diabetic Patients Are At Risk For Fournier's Gangrene | 8/7/2019
- Florida Nursing Home Death May Have Been From Fournier's Gangrene | 8/1/2019
- There is an Outbreak of The Flesh-Eating Disease Along America's Eastern Beaches | 7/23/2019
- Fournier's Gangrene Should Not Be Confused With Everyday Necrotising Fasciitis | 7/11/2019
- Johnson & Johnson Needs To Do More To Alert Diabetics of The Flesh Eating Disease Caused By Invokana | 6/28/2019
- Diabetic Patients Living in Warmers Climates Are More at Risk to Contract Fournier's Gangrene | 6/13/2019
- The Warm Water Gulf of Mexico May Be a Breeding Ground For The Flesh Eating Disease Bacteria | 6/7/2019
- Diabetic Patients in Nursing Homes Are Ground Zero For Fournier's Gangrene | 5/30/2019
- Several New Cases Of Flesh Eating Disease Have Been Recently Reported | 5/23/2019
- Cases Of Fournier's Gangrene Increases From 12 to 55 In The Latest Peer Reviewed Medical Study | 5/13/2019
- People Are Developing The Flesh-Eating Disease In Various Ways | 4/30/2019
- Most Doctors Remain Unaware of Fournier's Gangrene and May Misdiagnose Patients | 4/19/2019
- World Governments Are Expressing Concern That Certain Diabetes Drugs Can Cause Fournier's Gangrene | 4/15/2019
- Diabetic Drugs Can Have Serious Side Effects | 4/2/2019
- Necrotising Fasciitis Effects Everyone From All Walks of Life | 3/29/2019
- Cases of Fourniers Gangrene Are Steadily Increasing Around The World | 3/25/2019
- Global Warming and Climate Change May Be Contributing to Increases In Flesh Eating Diseases | 3/11/2019
- Early Warning Signs That You May Have Fournier's Gangrene or Other Flesh-Eating Disease | 3/6/2019
- Scientists Are Encouraged By Data From Flesh-Eating Disease Studies | 2/25/2019
- The Brief History of Fournier's Gangrene | 2/20/2019
- Diabetic Drug Warnings Admit to Causing Narcotizing Fasciitis Not Fournier's Gangrene Specifically | 2/11/2019
- Fournier's Gangrene Statistics May Be Greater Than Reported | 2/5/2019
- Diabetic Patients and Others Are At Risk For Fournier's Gangrene | 1/29/2019
- Fournier's Gangrene Frequently Asked Questions | 1/23/2019
- Diabetes Drugs Must Include Fournier's Gangrene Warning | 1/18/2019
- A Nursing Home's Elderly Diabetic Population Most at Risk For Fournier's Gangrene | 1/10/2019
- Diabetic Patients Should Be Vigilant In Watching For The Symptoms Of Fournier's Gangrene, A Flesh-Eating Disease That Can Affect The Genital Region | 1/4/2019
- An Indian Man Has Died of Fournier's Gangrene in a UK Hospital | 12/31/2018
- Pictures of Fournier's Gangrene Are Grotesque and Indescribable | 12/22/2018
- A Florida Nursing Home Patient Death Could be the 13th Case of Fournier's Gangrene | 12/20/2018
- Florida Man Dies From Genital Gangrene Quite Possibly Fournier's Gangrene | 12/15/2018
- The FDA's Fournier's Gangrene Warning is Shocking Diabetes Patients | 12/12/2018
- Drug Websites Carry The Clearest Fournier's Gangrene Amputation Warnings | 12/1/2018
- Recent FDA Warning Alerts Diabetes Patients To Watch For Signs of Genital Flesh-Eating Disease | 11/21/2018
- Diabetes Drugs May Cause Flesh-Eating Disease Affecting The Genitals | 11/1/2018
Lawyers for Fournier's Gangrene
OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.